Pricing Log in Create free account

Citius Pharmaceuticals, Inc. (CTXR) vs Kyntra Bio Inc (KYNB)

Citius Pharmaceuticals, Inc. and Kyntra Bio Inc are both Biotechnology companies. Citius Pharmaceuticals, Inc. and Kyntra Bio Inc are of similar size ($15.3M and $14.8M). Citius Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.1×. Kyntra Bio Inc has the higher net margin (3,967.8% vs 0.00%) and the higher return on invested capital (0.00% vs −58.7%). Across the 13 metrics below, Kyntra Bio Inc leads on 8 and Citius Pharmaceuticals, Inc. on 5.

Valuation

Metric CTXR KYNB Biotechnology median
P/E n/m 0.08 10.60
P/S n/m 3.37 9.40
P/B 0.19 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 15.46 9.02
Earnings yield (387.87%) 1,179.69% (32.88%)
Free cash flow yield (242.31%) (245.05%) (23.13%)

Profitability

Metric CTXR KYNB Biotechnology median
Gross margin 0.00% 6.28% 68.51%
Operating margin 0.00% (1,089.78%) 0.00%
Net margin 0.00% 3,967.77% 0.00%
Free cash flow margin 0.00% (824.19%) 0.00%
Return on equity (64.51%) (157.83%) (51.96%)
Return on assets (34.29%) 131.26% (46.06%)
Return on invested capital (58.74%) 0.00% 0.00%

Growth

Metric CTXR KYNB Biotechnology median
Revenue growth (TTM) — (37.15%) 6.76%
EPS growth (last fiscal year) 43.38% 478.08% 29.88%
Revenue growth, 5-year CAGR — (48.42%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTXR KYNB Biotechnology median
Debt to equity 0.08 0.00 0.00
Current ratio 0.84 2.69 4.97
Net debt to EBITDA 0.11 1.97 1.01

Dividend

Metric CTXR KYNB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CTXR KYNB Biotechnology median
Market cap 15.31m 14.82m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack